Miocarditis por SARS-CoV-2. Una breve revisión

Myocarditis is an important cardiovascular complication of COVID-19, a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been observed that hospitalized patients with pre-existing cardiac disease are at higher risk for the development of this complication. It is predominantly male, with the most affected population being adults over 50 years of age and pediatrics; however, its incidence and prevalence are not completely known. This disease is caused by direct and indirect lesions caused by SARS-CoV-2 infection to the myocardiocyte and other cells. Clinical manifestations vary from mild, such as fatigue and dyspnea, to severe, such as cardiogenic shock. Tests for the detection of this pathology are laboratory, imaging and histological. In this article we briefly review SARS-CoV-2 myocarditis in epidemiology, pathophysiology, clinic, diagnosis, treatment, as well as vaccination myocarditis.